###begin article-title 0
###xml 55 60 <span type="species:ncbi:9606">Human</span>
Convergence of IL-1beta and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses
###end article-title 0
###begin p 1
Conceived and designed the experiments: PTL MS PWD GC RM. Performed the experiments: PTL MS VPW MK MW AV XZ. Analyzed the data: PTL MS VPW. Contributed reagents/materials/analysis tools: AS UZ BH. Wrote the paper: PTL RM.
###end p 1
###begin p 2
###xml 140 146 <span type="species:ncbi:9606">humans</span>
Antimicrobial effector mechanisms are central to the function of the innate immune response in host defense against microbial pathogens. In humans, activation of Toll-like receptor 2/1 (TLR2/1) on monocytes induces a vitamin D dependent antimicrobial activity against intracellular mycobacteria. Here, we report that TLR activation of monocytes triggers induction of the defensin beta 4 gene (DEFB4), requiring convergence of the IL-1beta and vitamin D receptor (VDR) pathways. TLR2/1 activation triggered IL-1beta activity, involving the upregulation of both IL-1beta and IL-1 receptor, and downregulation of the IL-1 receptor antagonist. TLR2/1L induction of IL-1beta was required for upregulation of DEFB4, but not cathelicidin, whereas VDR activation was required for expression of both antimicrobial genes. The differential requirements for induction of DEFB4 and cathelicidin were reflected by differences in their respective promoter regions; the DEFB4 promoter had one vitamin D response element (VDRE) and two NF-kappaB sites, whereas the cathelicidin promoter had three VDREs and no NF-kappaB sites. Transfection of NF-kappaB into primary monocytes synergized with 1,25D3 in the induction of DEFB4 expression. Knockdown of either DEFB4 or cathelicidin in primary monocytes resulted in the loss of TLR2/1-mediated antimicrobial activity against intracellular mycobacteria. Therefore, these data identify a novel mechanism of host defense requiring the induction of IL-1beta in synergy with vitamin D activation, for the TLR-induced antimicrobial pathway against an intracellular pathogen.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 195 221 195 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 533 536 529 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Wang1">[1]</xref>
###xml 537 540 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Krutzik1">[5]</xref>
###xml 721 724 717 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu3">[6]</xref>
###xml 195 221 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 714 720 <span type="species:ncbi:9606">humans</span>
The innate immune system rapidly responds to infectious pathogens, through recognition of microbial ligands and subsequent triggering of an antimicrobial response. For the intracellular pathogen Mycobacterium tuberculosis, a key antimicrobial mechanism involves recognition of bacterial lipoproteins by Toll-like receptors (TLRs), induction of the 25-hydroxyvitamin D3-1alpha-hydroxylase (CYP27B1), which converts the vitamin D prohormone (25D) into the active 1,25D form, upregulation and activation of the vitamin D receptor (VDR) [1]-[5]. Single nucleotide polymorphisms in the VDR confer increased susceptibility to tuberculosis, suggested a key role for VDR activation in host defense against tuberculosis in humans [6].
###end p 4
###begin p 5
###xml 117 132 117 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 223 226 223 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Rook1">[7]</xref>
###xml 228 231 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Crowle1">[8]</xref>
###xml 362 377 362 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 545 548 545 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Wang1">[1]</xref>
###xml 611 626 611 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 626 629 626 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu1">[3]</xref>
###xml 733 736 733 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 831 834 831 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 117 132 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 187 191 <span type="species:ncbi:75140">Rook</span>
###xml 362 377 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 611 626 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 945 950 <span type="species:ncbi:9606">human</span>
It has long been known that activation of the VDR alone in human monocytes induces an antimicrobial activity against M. tuberculosis, first demonstrated in the laboratories of Crowle and Rook by addition of the VDR agonist [7], [8]. We reasoned that the VDR-induced antimicrobial pathway involves a set of regulated genes that contribute to host defense against M. tuberculosis infection. Vitamin D receptor response elements (VDREs) have been shown to regulate the antimicrobial peptides cathelicidin and defensin beta 4 (DEFB4, formerly HBD2) [1]. Previously, we demonstrated that cathelicidin directly kills M. tuberculosis[3], and furthermore, vitamin D-induced expression of cathelicidin was required for antimicrobial activity [4]. In contrast, VDR activation alone was not sufficient to induce DEFB4 expression in monocytes [4]. Here we investigated the mechanism by which activation of the innate system could induce DEFB4 expression in human monocytes.
###end p 5
###begin title 6
Materials and Methods
###end title 6
###begin title 7
Ethics statement
###end title 7
###begin p 8
This study was conducted according to the principles expressed in the Declaration of Helsinki. The study was approved by the Institutional Review Board of the University of California at Los Angeles. All donors provided written informed consent for the collection of peripheral blood and subsequent analysis.
###end p 8
###begin title 9
Reagents and bacteria
###end title 9
###begin p 10
###xml 30 45 30 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 347 349 347 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 464 466 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 474 476 468 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 485 487 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 709 711 703 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 719 721 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 730 732 724 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 766 781 760 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1768 1771 1745 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Sanjabi1">[9]</xref>
###xml 30 45 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 602 607 <span type="species:ncbi:9606">human</span>
###xml 766 787 <span type="species:ncbi:419947">M. tuberculosis H37Ra</span>
TLR2/1L is a synthetic 19 kDa M. tuberculosis derived lipopeptide (EMC Microcollections, Tuebingen, Germany). Optimal induction of cathelicidin by TLR2/1L was performed at 24 hours based on previous time course experiments (data not shown). 1,25D3 was purchased (BioMol, Plymouth Meeting, PA, USA) and resuspended in sterile filtered ethanol at 10-2 M in amber tubes and stored at -80degreesC in small aliquots. 1,25D3 was added to culture at a concentration of 10-7 M to 10-9 M, or 10-8 M in the absence of a titration, the concentration previously determined to be optimal for provocation of primary human monocytes. VDR antagonist ZK 159 222 (VAZ) was provided from Bayer Schering Pharma AG, and used at 10-7 M to 10-9 M, or 10-8 M in the absence of a titration. M. tuberculosis H37Ra strain was a kind gift from Dr. J. Ernst and utilized as described below. Cathelicidin (Phoenix Pharmaceuticals, Burlingame, CA) and DEFB4 (Peptides International, Louisville, KY) peptides were purchased and stored as recommended by the manufacturer. The nonspecific peptide control is the 1-40 amino acids of the amyloid-beta protein (Peptides International), selected for its similarity in both length and molecular weight to cathelicidin and DEFB4 peptides, and it has no known antimicrobial activity. Predesigned siRNA oligos were purchased (Dharmacon, Lafayette, CO): siCTRL, siCath, and siDEFB4 were resuspended and stored as recommended by the manufacturer. Cell Line Nucleofection Kit V was purchased and used for siRNA transfections (Amaxa, Gaithersburg, MD). IL-1beta neutralizing antibody and recombinant IL-1beta were purchased and used at 10 microg/ml and 10 ng/ml respectively (R&D Systems, Minneapolis, MN). NF-kappaB p65 expression vector was previously described [9].
###end p 10
###begin title 11
Monocyte Isolation and Serum collection
###end title 11
###begin p 12
###xml 493 496 493 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 174 179 <span type="species:ncbi:9606">human</span>
Monocytes were isolated using Ficoll-Paque followed by Percoll gradients (Amersham Biosciences, Piscataway, NJ) and cultured with RPMI containing 10% of vitamin D-sufficient human sera, and stimulated with the indicated conditions. For serum collections, blood was drawn with no anticoagulants, and allowed to clot for one hour. Then the clot was disrupted and centrifuged to separate the serum, which was isolated and filtered. Both 25D and 1,25D levels were measured as previously described [4]. Sera from multiple vitamin D sufficient or borderline insufficient donors were pooled and the bulk sera were supplemented with exogenous 25D3 to achieve 100 nM concentration if needed.
###end p 12
###begin title 13
ELISA and Flow Cytometry
###end title 13
###begin p 14
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu4">[10]</xref>
###xml 166 171 <span type="species:ncbi:9606">Human</span>
###xml 742 747 <span type="species:ncbi:9606">human</span>
ELISAs were performed as previously described [10]. The IL-1beta antibody pair was purchased (Invitrogen, Carlsbad, CA). For measuring IL-1RA levels, we utilized the Human IL-1RA Duoset ELISA kit as recommended by the manufacturer (R&D System). Detection of cell surface IL-1R1 levels was achieved using a three-step flow cytometry assay. Briefly, following TLR2/1L stimulation, cells were harvested from the culture plate and incubated with the primary monoclonal antibody against IL-1R1 (R&D Systems), then a biotinylated secondary antibody, and finally strep-avidin conjugated with a fluorochrome. The three step flow cytometry is necessary for the amplification of the fluorescent signal due to the low expression levels of the IL-1R1 on human primary monocytes.
###end p 14
###begin title 15
Direct antimicrobial activity assay
###end title 15
###begin p 16
###xml 69 84 69 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 283 286 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu1">[3]</xref>
###xml 288 291 288 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 408 423 408 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 460 463 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 598 599 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 69 84 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 408 429 <span type="species:ncbi:419947">M. tuberculosis H37Ra</span>
Our previous studies demonstrate that the attenuated H37Ra strain of M. tuberculosis has a similar susceptibility to cathelicidin compared to the virulent H37Rv strain; therefore, we felt that H37Ra is a sufficient model for the effects of antimicrobial peptides on bacterial growth [3], [4]. The direct antimicrobial experiments were performed in conditions that are optimized for cathelicidin activity and M. tuberculosis H37Ra grown as previously described [4]. Briefly 2x106 bacteria are incubated with cathelicidin, DEFB4 or a non-specific peptide for two days, and then pulsed with 3 microCi 3H-uracil for one day. Following incubation, the bacteria were fixed at a final concentration of 2% paraformaldehyde for 20 minutes then harvested for liquid scintillation counting. Antimicrobial activity was calculated as the percent decrease in CPM values following treatment with the peptide as compared to the no peptide control.
###end p 16
###begin title 17
CFU Assay
###end title 17
###begin p 18
###xml 43 58 43 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 781 782 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 814 817 814 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu1">[3]</xref>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 43 64 <span type="species:ncbi:419947">M. tuberculosis H37Ra</span>
Primary human monocytes were infected with M. tuberculosis H37Ra at an MOI of 0.5 for 16 hours. The efficiency of infection was determined by auramine rhodamine stain and was regularly in the range of 30%, with an average of 1.1 bacteria per infected cell. Infected cells were washed with 1xPBS to remove extracellular bacteria, counted, and plated into 96 well culture plates. The infected cells were treated with TLR2/1L for three days in triplicate wells, then lysed by resuspension into a 0.3% solution of saponin with vigorous pipetting. Intracellular bacteria were harvested for CFU assay as described [4]. To normalize for the variable starting material per experiment, the relative CFU were calculated by extrapolating the relative values of the TLR2/1L-treated cells to 105 CFU of the media treated cells [3].
###end p 18
###begin title 19
qPCR
###end title 19
###begin p 20
###xml 240 243 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Miller1">[11]</xref>
###xml 431 435 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Monney1">[12]</xref>
RNA was isolated using Trizol Reagent (Invitrogen), and cDNA was synthesized using the iSCRIPT cDNA Synthesis Kit (BioRad, Hercules, CA). The primer sequences for 36B4, DEFB4 and cathelicidin were previously published and methods described [4], [11]. The relative quantities of the gene tested per sample were calculated against the ribosomal protein, large, P0 mRNA (36B4) using the DeltaDeltaC(T) formula as previously described [12].
###end p 20
###begin title 21
Primary monocyte transfection
###end title 21
###begin p 22
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:9606">Human</span>
Transfection of either siRNA or expression constructs into primary human monocytes was accomplished using the Amaxatrade mark Nucleofection System and the Human Monocyte Kit according to the manufacturer's recommendations. siRNA constructs were used at 100 pmol per transfection, and plasmids at 1 microg per transfection. Transfection efficiency of siRNA into primary monocytes was assessed using siGLO, a fluorescently labeled control oligo (Dharmacon) and averaged 95% transfection rate. Transfection efficiency of expression constructs was assessed using the pMAX-GFP construct (Amaxa), and yielded an average of 38% transfection rate.
###end p 22
###begin title 23
Results
###end title 23
###begin title 24
TLR2/1-activation results in upregulation of DEFB4 mRNA
###end title 24
###begin p 25
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 225 234 225 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g001">Figure 1a</xref>
###xml 236 239 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 311 313 311 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 520 523 520 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 412 417 <span type="species:ncbi:9606">human</span>
As previously reported, direct activation of the VDR in primary monocytes with 1,25D3 (10-8 M) did not induce DEFB4 mRNA, but was sufficient to induce a 25 fold increase in cathelicidin expression (Student's t-test, p<0.05) (Figure 1a) [4]. Similarly, DEFB4 was not induced by monocytes activated with either 10-7 M or 10-9 M concentrations of 1,25D3 (data not shown). The induction of cathelicidin by 1,25D3 in human monocytes, and as previously shown the downstream target CYP24A1 suggested that the VDR is functional [4], yet its activation is not sufficient to induce DEFB4.
###end p 25
###begin title 26
Induction of antimicrobial peptides DEFB4 and cathelicidin from monocytes.
###end title 26
###begin p 27
###xml 61 63 61 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 12 17 <span type="species:ncbi:9606">human</span>
(A) Primary human monocytes were stimulated with 1,25D3 at 10-8 M for 18 hours. Levels of DEFB4 or cathelicidin mRNA were determined using qPCR. (mean fold change vs media+/-SEM, n>/=5). (B) Monocytes were stimulated with the TLR2/1L (10 microg/ml) for 24 hours. Levels of DEFB4 or cathelicidin mRNA were determined using qPCR. (mean fold change vs media+/-SEM, n>/=4). NS = not significant, * = p</=0.05, ** = p</=0.01.
###end p 27
###begin p 28
###xml 324 339 324 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 521 530 521 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g001">Figure 1b</xref>
###xml 566 569 566 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 324 339 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 829 834 <span type="species:ncbi:9606">human</span>
To determine if other pathways were involved in the induction of DEFB4 in monocytes, we considered TLR2/1 activation, a powerful inducer of innate immune responses in monocytes, including activation of the VDR as well as other signaling pathways. In contrast to 1,25D3 stimulation, activation by the TLR2/1 ligand (TLR2/1L, M. tuberculosis derived 19 kDa lipopeptide) resulted in upregulation of DEFB4 mRNA by 4.2 fold (t-test, p<0.005). Cathelicidin was upregulated by 2.6 fold (t-test, p<0.05) in the same experiments (Figure 1b), consistent with previous results [4]. The TLR2/1L-induced DEFB4 mRNA expression levels ranged from two to ten fold over media control, with induction in some donors reaching levels of 30 to 70 fold over media control (data not shown). These data indicate that DEFB4 induction can be triggered in human monocytes through activation of TLR2/1.
###end p 28
###begin title 29
TLR2/1-induced DEFB4 mRNA is dependent on activation of the VDR
###end title 29
###begin p 30
###xml 361 363 361 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 371 373 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 403 405 403 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 589 598 589 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g002">Figure 2a</xref>
###xml 644 646 644 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 987 996 987 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g002">Figure 2b</xref>
###xml 59 64 <span type="species:ncbi:9606">human</span>
The ability of TLR2/1L but not 1,25D3 to activate DEFB4 in human monocytes raised the question as to whether VDR activation was required for DEFB4 induction. In order to address this, the VDR antagonist ZK 159 222 (VAZ) was first tested for its ability to block 1,25D3-induced cathelicidin mRNA expression. Preincubation of monocytes with a titration of VAZ (10-9 M to 10-7 M) reduced 1,25D3-induced (10-8 M) cathelicidin mRNA in a dose dependent manner, resulting in a 56% reduction (t-test, p<0.05) at equimolar concentrations and 87% reduction (t-test, p<0.05) at 10-fold molar excess (Figure 2a). Monocytes were then pretreated with VAZ (10-8 M) followed by the TLR2/1L for 24 hours. mRNA levels of DEFB4 and cathelicidin were assessed using qPCR. In the presence of VAZ, the TLR2/1L-mediated DEFB4 was reduced by 98% (t-test, p<0.001) and cathelicidin mRNA expression was completely inhibited to levels below unstimulated background calculated as a 120% reduction (t-test, p<0.01) (Figure 2b). Taken together, these data demonstrate that TLR2/1L-mediated induction of DEFB4 mRNA is dependent on activation of the VDR.
###end p 30
###begin title 31
Role of vitamin D receptor activation on the TLR2/1-induced DEFB4 expression.
###end title 31
###begin p 32
###xml 84 86 84 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 100 102 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 313 315 311 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
(A) Monocytes were treated with vitamin D receptor antagonist ZK 159 222 (VAZ) at 10-7 M, 10-8 M, 10-9 M or media for 20 minutes then activated with 1,25D3 at 10-8 M for 18 hours. Levels cathelicidin mRNA were determined using qPCR. (mean fold change vs media+/-SEM, n = 4). (B) Monocytes were treated with VAZ 10-8 M or media for 20 minutes then activated with the TLR2/1L (10 microg/ml) for 24 hours. Levels of DEFB4 or cathelicidin mRNA were determined using qPCR (mean fold change vs media+/-SEM, n>/=4). * = p</=0.05, ** = p</=0.01.
###end p 32
###begin title 33
IL-1beta is required for TLR2/1L-mediated induction of DEFB4 mRNA
###end title 33
###begin p 34
###xml 364 367 358 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Wang1">[1]</xref>
###xml 442 446 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Fenton1">[13]</xref>
###xml 448 452 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Watson1">[14]</xref>
###xml 927 936 909 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g003">Figure 3a</xref>
###xml 522 527 <span type="species:ncbi:9606">human</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
The findings that TLR2/1-mediated induction of DEFB4 is VDR-dependent, but 1,25D3 alone was not a sufficient trigger, suggested that in addition, TLR2/1 activation induces a VDR-independent immune mechanism. We hypothesized that IL-1beta mediated the TLR2/1-induced DEFB4 expression given that: i) IL-1beta was able to trigger DEFB4 expression in epithelial cells [1] and ii) TLR activation of monocytes resulted in the secretion of IL-1beta [13], [14]. To determine whether TLR2/1-dependent induction of DEFB4 in primary human monocytes required production of IL-1beta, monocytes were pretreated with IL-1beta neutralizing monoclonal antibody, or IgG isotype control for 20 minutes then cultured in human serum and stimulated with TLR2/1L. The presence of the IL-1beta neutralizing antibody resulted in 97% reduction in the TLR2/1L-induced DEFB4 mRNA expression (t-test, p<0.05), but had no effect on cathelicidin expression (Figure 3a). These data suggest that induction of IL-1beta is required for TLR2/1-mediated induction of DEFB4 but not cathelicidin.
###end p 34
###begin title 35
Role of IL-1beta activation on DEFB4 expression.
###end title 35
###begin p 36
(A) Monocytes were incubated with the IL-1beta neutralizing antibody (10 microg/ml), isotype control (10 microg/ml) or media for 20 minutes, and then activated with TLR2/1L (10 microg/ml) for 24 hours. Levels of DEFB4 or cathelicidin mRNA were determined using qPCR (mean fold change vs media+/-SEM, n>/=4). (B) Monocytes were stimulated with either media, TLR2/1L (10 microg/ml), recombinant IL-1beta (10 ng/ml), or both for 24 hours. Levels of DEFB4 or cathelicidin mRNA were determined using qPCR (mean fold change vs media+/-SEM, n = 5). NS = not significant, * = p</=0.05, ** = p</=0.01.
###end p 36
###begin p 37
###xml 207 209 201 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 488 497 476 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g003">Figure 3b</xref>
###xml 647 656 632 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g003">Figure 3b</xref>
###xml 170 175 <span type="species:ncbi:9606">human</span>
Given these results, we tested if co-stimulation of monocytes with IL-1beta and 1,25D3 could induce DEFB4 expression. Monocytes stimulated with either media, recombinant human IL-1beta (10 ng/ml), 1,25D3 (10-8 M), or IL-1beta and 1,25D3 together for 24 hours and assayed for DEFB4 and cathelicidin mRNA expression. IL-1beta alone did not induce expression of either DEFB4 or cathelicidin mRNA, and 1,25D3 alone induced a 50-fold increase in cathelicidin mRNA expression (t-test, p<0.01) (Figure 3b). However, when added together, IL-1beta and 1,25D3 did not induce DEFB4 mRNA, despite a 40-fold upregulation of cathelicidin mRNA (t-test, p<0.01) (Figure 3b). These results indicate that TLR2/1-induced DEFB4 mRNA expression requires the release of both IL-1beta and activation of the VDR, but the addition of IL-1beta and the VDR agonist together are not sufficient to induce DEFB4 mRNA expression.
###end p 37
###begin title 38
TLR2/1L triggers IL-1beta, IL-1R1 and inhibits IL-1RA from monocytes
###end title 38
###begin p 39
###xml 890 899 855 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g004">Figure 4a</xref>
###xml 1071 1080 1036 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g004">Figure 4b</xref>
###xml 1400 1409 1361 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g004">Figure 4c</xref>
###xml 1498 1507 1459 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g004">Figure 4d</xref>
###xml 493 498 <span type="species:ncbi:9606">human</span>
We hypothesized that TLR2/1 activation on monocytes leads to potentiation of IL-1beta function based upon the following observations, 1) both IL-1beta and activation of the VDR are required for TLR2/1-mediated induction of DEFB4, and 2) co-stimulation with IL-1beta and 1,25D3 did not induce DEFB4. Therefore, three key factors that can influence IL-1beta activity were assayed in TLR2/1 stimulated monocytes: IL-1beta+/-IL-1 receptor antagonist (IL-1RA) and IL-1 receptor 1 (IL-1R1). Primary human monocytes were isolated and treated with a titration of TLR2/1L (0.1 microg/ml, 1 microg/ml, and 10 microg/ml) for 18 hours, then IL-1beta and IL-1RA levels in the culture supernatants were measured using ELISA. TLR2/1 stimulation resulted in significant IL-1beta secretion in a dose dependent manner reaching 2.8 ng/ml at the highest TLR2/1L concentration tested (t-test vs media, p<0.05) (Figure 4a). Although monocytes cultured in media alone exhibited spontaneous production of IL-1RA, the addition of TLR2/1L reduced the release of IL-1RA in a dose dependent manner (Figure 4b). At the highest concentration of TLR2/1L (10 ug/ml) IL-1RA was reduced by 60% as compared to media (t-test, p<0.01). Next, cell surface expression of IL-1R1 on monocytes stimulated with either media or TLR2/1L (10 microg/ml) was measured by flow cytometry. TLR2/1 activation resulted in enhanced expression of IL-1R1 (Figure 4c) equaling an average 3.1 fold increase in mean fluorescence intensity (t-test, p<0.05) (Figure 4d). Taken together, these data demonstrate that TLR2/1 stimulation of monocytes increases IL-1beta activity through the secretion of IL-1beta, increased expression of IL-1R1 and inhibition of IL-1RA.
###end p 39
###begin title 40
Regulation of IL-1beta activity by TLR activation.
###end title 40
###begin p 41
Monocytes were stimulated with the TLR2/1L at 0.1 microg/ml, 1 microg/ml or 10 microg/ml for 18 hours. (A) IL-1beta or (B) IL-1RA levels in culture supernatants were measured using ELISA (mean levels+/-SEM, n = 5). Monocytes were stimulated with TLR2/1L (10 microg/ml) for 24 hours. Cell surface expression of IL-1R1was assayed using flow cytometry. Data shown are (C) representative of three individual donors, or (D) the mean DeltaMFI (n = 3). (E) Monocytes stimulated with either media, TLR2/1L (10 microg/ml), recombinant IL-1beta (10 ng/ml) or both for 24 hours. Levels of DEFB4 or cathelicidin mRNA were determined using qPCR (mean fold change vs media+/-SEM, n = 5). NS = not significant, * = p</=0.05, ** = p</=0.01.
###end p 41
###begin p 42
###xml 514 523 505 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g004">Figure 4e</xref>
###xml 821 830 809 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g004">Figure 4e</xref>
###xml 973 982 958 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005810.s001">Figure S1</xref>
###xml 205 210 <span type="species:ncbi:9606">human</span>
We hypothesized that TLR2/1 stimulated monocytes would be more sensitive to IL-1beta stimulation due to the higher IL-1R1 expression and lower IL-1RA secretion. To test this, primary monocytes cultured in human serum were treated with media, recombinant IL-1beta, TLR2/1L, or both simultaneously for 24 hours and assayed for DEFB4 and cathelicidin mRNA expression. Consistent with the previous results, addition of recombinant IL-1beta to the culture medium alone did not induce either DEFB4 or cathelicidin mRNA (Figure 4e), and again, TLR2/1L induced expression of DEBF4 and cathelicidin mRNAs. However, when monocytes were co-treated with both IL-1beta and TLR2/1L, DEFB4 mRNA expression levels were synergistically increased by three fold over TLR2/1L alone (t-test, p<0.01), but cathelicidin levels were unaffected (Figure 4e). In addition, IL-1beta did not increase the TLR2/1-induced expression of either CYP27B1 or the VDR, both key genes in the vitamin D pathway (Figure S1). These experiments demonstrate that TLR2/1 stimulation sensitizes monocytes to IL-1beta activation.
###end p 42
###begin title 43
NF-kappaB activation drives expression of DEFB4 mRNA in monocytes
###end title 43
###begin p 44
###xml 463 472 460 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g005">Figure 5a</xref>
###xml 652 661 645 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g005">Figure 5a</xref>
###xml 758 767 751 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 829 832 822 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Wang1">[1]</xref>
###xml 834 838 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Kao1">[15]</xref>
In order to gain insight into the underlying mechanism for the differential requirements for IL-1beta activation of monocytes in the induction of DEFB4 versus cathelicidin, their respective upstream promoters regions were analyzed for regulatory elements by MatInspector. Three vitamin D receptor response elements (VDREs) were located in the cathelicidin promoter at positions -144, -502, and -653 as compared to only one in the DEFB4 promoter at position -938 (Figure 5a). Interestingly, there were two NF-kappaB response elements found in the DEFB4 promoter at positions -406 and -795, whereas none were present in the cathelicidin promoter region (Figure 5a). Previously published studies have verified all of the above mentioned response elements to be bona fide promoter elements for their respective transcription factors [1], [15].
###end p 44
###begin title 45
Role of NF-kappaB activation on TLR2/1-induced DEFB4.
###end title 45
###begin p 46
###xml 296 298 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 230 233 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) Promoter analysis for 1 kb upstream region for cathelicidin and DEFB4, representing NF-kappaB binding sites and vitamin D response elements (VDRE). Monocytes were transfected with either an NF-kappaB p65 expression construct (CMV-p65) or a control plasmid, and then stimulated with 1,25D3 (10-8 M) for 18 hours. (B) DEFB4 and (C) cathelicidin mRNA levels were determined using qPCR (mean fold change vs media+/-SEM, n = 6). * = p</=0.05.
###end p 46
###begin p 47
###xml 350 354 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Kao1">[15]</xref>
###xml 356 360 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Morello1">[16]</xref>
###xml 787 796 768 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g005">Figure 5b</xref>
###xml 923 932 904 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g005">Figure 5b</xref>
###xml 1185 1194 1166 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g005">Figure 5b</xref>
###xml 381 386 <span type="species:ncbi:9606">human</span>
###xml 487 490 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 506 509 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 549 552 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 712 715 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 799 802 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 970 973 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1150 1153 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1224 1229 <span type="species:ncbi:9606">human</span>
Based upon the presence of two NF-kappaB response elements in the DEFB4 promoter, we determined whether NF-kappaB activation could trigger monocytic expression of DEFB4 mRNA. IL-1beta has been shown to induce the activation and nuclear translocation of the p65 and p50 NF-kappaB subunits, but does not activate c-Rel, RelB or p52 in epithelial cells [15], [16]. Therefore, primary human monocytes were transfected with a plasmid expressing the p65 NF-kappaB subunit under control of the CMV-promoter, or a CMV-GFP control plasmid. In the context of CMV-p65 transfection, 1,25D3 stimulation of monocytes resulted in a significant 4.6 fold increase in DEFB4 mRNA expression (t-test, p<0.05, n = 6), whereas in the CMV-GFP control transfected cells, 1,25D3 did not induce DEFB4 expression (Figure 5b). CMV-p65 also induced a trend for increasing DEFB4 expression (t-test, p = 0.14, n = 6) in the absence of additional 1,25D3 (Figure 5b). On the other hand, transfection of CMV-p65 trended towards inhibition of the 1,25D3 induced cathelicidin expression by 77% (t-test, p = 0.08, n = 6) as compared to the 1,25D3 elicited cathelicidin expression in the CMV-GFP control transfected cells (Figure 5b). These data suggest that in human monocytes, activation of both NF-kappaB and VDR response elements are required for optimal induction of DEBF4.
###end p 47
###begin title 48
DEFB4 peptide exhibits direct antimicrobial activity
###end title 48
###begin p 49
###xml 65 80 65 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-RivasSantiago1">[17]</xref>
###xml 225 240 225 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 490 491 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 620 623 612 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Martineau1">[2]</xref>
###xml 625 628 617 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 799 808 791 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g006">Figure 6a</xref>
###xml 1003 1012 991 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g006">Figure 6b</xref>
###xml 1086 1101 1074 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 65 80 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 225 240 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1086 1101 <span type="species:ncbi:1773">M. tuberculosis</span>
Although human DEFB4 has been demonstrated to be associated with M. tuberculosis in alveolar macrophages during infection [17], the antimicrobial activity of DEFB4 against the bacterium has not been studied. To address this, M. tuberculosis (attenuated H37Ra strain) were incubated with DEFB4 peptide, or cathelicidin peptide (LL-37), as well as an unrelated control peptide (CTRL), at a range from 0.01 microg/ml to 10 microg/ml for three days. Bacterial viability was then assessed using 3H-uracil uptake assay. Cathelicidin peptide demonstrated a dose dependent antimicrobial activity, corroborating previous results [2], [4]. The DEFB4 peptide demonstrated similar dose dependent antimicrobial capacity to cathelicidin. In contrast, the control peptide was unable to reduce bacterial viability (Figure 6a). The observed antimicrobial activity for DEFB4 and cathelicidin at 10 microg/ml compared to the control peptide was calculated as 44% (t-test, p<0.001) and 41% (t-test, p<0.001), respectively (Figure 6b). These results demonstrate that DEFB4 is directly antimicrobial against M. tuberculosis.
###end p 49
###begin title 50
Direct antimicrobial activity of DEFB4 and cathelicidin peptides.
###end title 50
###begin p 51
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 237 238 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 0 21 <span type="species:ncbi:419947">M. tuberculosis H37Ra</span>
M. tuberculosis H37Ra were incubated with a control peptide, DEFB4 peptide or cathelicidin peptide at 0.01 microg/ml, 0.1 microg/ml, 1 microg/ml and 10 microg/ml as well as media for three days. Bacterial proliferation was assayed using 3H-uracil up take. Data shown is (A) representative of three independent experiments, and (B) mean antimicrobial activity+/-SEM (n>/=5). * = p</=0.05, ** = p</=0.01, *** = p</=0.001.
###end p 51
###begin title 52
Both DEFB4 and cathelicidin are required for TLR2/1-mediated antimicrobial activity
###end title 52
###begin p 53
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu1">[3]</xref>
###xml 729 738 729 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005810.s002">Figure S2</xref>
###xml 290 295 <span type="species:ncbi:9606">human</span>
We have previously demonstrated that induction of cathelicidin was required for 1,25D3-mediated antimicrobial activity [3]. To compare the role of DEFB4 and cathelicidin in the TLR2/1-mediated antimicrobial pathway, siRNA technology was used to knock down specific gene expression. Primary human monocytes were transfected with siRNA oligos complementary to the DEFB4 mRNA (siDEFB4), the cathelicidin mRNA (siCath), or a non-specific control oligo (siCTRL). The transfected cells were treated with the TLR2/1L for 24 hours, and then expression of cathelicidin and DEFB4 mRNAs were measured. siDEFB4 and siCath both completely knocked-down the TLR2/1L-induced expression of their respective targets, whereas siCTRL had no effect (Figure S2).
###end p 53
###begin p 54
###xml 122 137 122 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 534 543 534 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g007">Figure 7a</xref>
###xml 660 669 660 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g007">Figure 7a</xref>
###xml 869 878 869 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g005">Figure 5b</xref>
###xml 1122 1131 1122 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g007">Figure 7b</xref>
###xml 122 143 <span type="species:ncbi:419947">M. tuberculosis H37Ra</span>
###xml 1317 1322 <span type="species:ncbi:9606">human</span>
Subsequently, monocytes transfected with siDEFB4, siCath and siCTRL as well as untransfected monocytes were infected with M. tuberculosis H37Ra at an MOI of 0.5 for 18 hours. The infected cells were then treated with media or TLR2/1L for three days, and their intracellular bacterial viability was determined by colony forming units assay (CFU). In one representative experiment, treatment with TLR2/1L reduced the viability of the intracellular bacteria in the untransfected and siCTRL transfected cells by 30% and 36% respectively (Figure 7a). In contrast, transfection of monocytes with siCath or siDEFB4 ablated the TLR2/1L-induced antimicrobial activity (Figure 7a). TLR2/1L treatment of untransfected and siCTRL transfected monocytes resulted in an average antimicrobial activity of 20% (t-test vs media, p<0.001) and 14% (t-test vs media, p<0.05), respectively (Figure 5b). However, transfection with siCath or siDEFB4 resulted in a 134% and 107% reduction of TLR2/1L-induced antimicrobial activity as compared to siCTRL transfected cells, respectively (t-test, p<0.05), indicating enhancement of bacterial growth (Figure 7b). These data suggest that the TLR2/1L-induced expression of both DEFB4 and cathelicidin are required for optimal antimicrobial activity against intracellular mycobacterial infection in human monocytes.
###end p 54
###begin title 55
Role of DEFB4 and cathelicidin in TLR-mediated antimicrobial activity.
###end title 55
###begin p 56
###xml 200 215 200 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 200 221 <span type="species:ncbi:419947">M. tuberculosis H37Ra</span>
Monocytes were transfected with either siRNA oligos specific for DEFB4 (siDEFB4) or cathelicidin (siCath) as well as a non-specific siRNA oligo (siCTRL) or no siRNA. The cells were then infected with M. tuberculosis H37Ra at an MOI of 0.5 for 18 hours followed by treatment with the TLR2/1L for three days. Intracellular bacterial load was measured using CFU assay. Data shown are (A) representative of six individual experiments, and (B) mean antimicrobial activity+/-SEM (n>/=6). * = p</=0.05, *** = p</=0.001.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 172 187 172 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 187 190 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 513 521 504 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005810-g008">Figure 8</xref>
###xml 172 187 <span type="species:ncbi:1773">M. tuberculosis</span>
The mechanisms by which TLR2/1 activation of monocytes triggers a vitamin D-dependent induction of antimicrobial activity are central to host defense against intracellular M. tuberculosis[4]. Here we demonstrate that convergence of IL-1beta and vitamin D transcriptional activation induced expression of the antimicrobial peptide DEFB4. Importantly, TLR2/1L activation triggered IL-1beta activity, involving the upregulation of both IL-1beta and IL-1 receptor, and downregulation of the IL-1 receptor antagonist (Figure 8). TLR2/1L induction of IL-1beta was required for upregulation of DEFB4, but not cathelicidin, whereas VDR activation was required for expression of both antimicrobial genes. A synergy between NF-kappaB and VDR activation was sufficient to upregulate expression of DEFB4. Finally, knockdown of either DEFB4 or cathelicidin resulted in the loss of TLR2/1-induced antimicrobial activity against intracellular mycobacteria. Therefore, these data identify a novel mechanism of host defense requiring the induction of two distinct signaling pathways, involving IL-1betain synergy with vitamin D activation, for TLR-induced antimicrobial activity against an intracellular pathogen.
###end p 58
###begin title 59
Model.
###end title 59
###begin p 60
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TLR2/1L-mediated antimicrobial activity in monocytes requires two distinct pathways. Triggering TLR2/1L results in activation of the vitamin D pathway, including expression of the VDR and CYP27B1, leading to induction of cathelicidin. On the other hand, TLR-mediated expression of DEFB4 requires convergence of the IL-1beta and VDR pathways. Activation of TLR2/1 results in regulation of IL-1beta activity, through the release of IL-1beta expression of its receptor, IL-1R1, and simultaneous downregulation of the IL-1RA. Both cathelicidin and DEFB4 are required for TLR2/1-mediated antimicrobial activity.
###end p 60
###begin p 61
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-ThomaUszynski1">[18]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-ThomaUszynski1">[18]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Chan2">[20]</xref>
###xml 664 667 664 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Wang1">[1]</xref>
###xml 764 767 764 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Gombart1">[21]</xref>
###xml 1048 1052 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Chang1">[22]</xref>
###xml 1433 1436 1433 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu3">[6]</xref>
###xml 1438 1442 1438 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Nicholson1">[23]</xref>
###xml 1444 1448 1444 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-MacMicking1">[24]</xref>
###xml 1514 1517 1514 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu3">[6]</xref>
###xml 1519 1523 1519 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Sly1">[25]</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 379 385 <span type="species:ncbi:10090">murine</span>
###xml 600 606 <span type="species:ncbi:9606">humans</span>
###xml 821 826 <span type="species:ncbi:10090">mouse</span>
###xml 958 964 <span type="species:ncbi:10090">murine</span>
###xml 1029 1035 <span type="species:ncbi:10090">murine</span>
###xml 1094 1100 <span type="species:ncbi:10090">murine</span>
###xml 1198 1203 <span type="species:ncbi:9606">human</span>
Upon triggering TLR2/1 with lipopeptide, both human and murine macrophages activate antimicrobial pathways against intracellular mycobacteria [4], [18]. In comparing the human and mouse TLR-induced antimicrobial pathways, it is noteworthy that the human antimicrobial response requires induction of multiple antimicrobial peptides, both cathelicidin and DEFB4, as opposed to the murine antimicrobial response which is dependent upon generation of nitric oxide [18]-[20]. It remains to be determined if the cathelicidin- and DEFB4-mediated antimicrobial activity is bactericidal or bacteriostatic. In humans, both the cathelicidin and DEFB4 promoters contain VDREs [1], VDR activation was required for their induction, as well as TLR-induced antimicrobial activity [4]. In contrast, there are no VDRE sites present in the mouse cathelicidin promoter region [21], and to our knowledge there are no other known vitamin D-dependent antimicrobial peptides in the murine genome. Interestingly, 1,25D induces nitric oxide generation in murine macrophages [22], although the role for vitamin D in this murine TLR-induced antimicrobial response remains to be determined. Although our data indicate that the human innate immune system has evolved a powerful antimicrobial mechanism against intracellular mycobacterial infection through the vitamin D dependent production of antimicrobial peptides, it does not preclude a role for nitric oxide [6], [23], [24] and other mechanisms such as superoxide generation and autophagy [6], [25].
###end p 61
###begin p 62
###xml 750 754 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Kao1">[15]</xref>
###xml 756 760 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Morello1">[16]</xref>
Although VDR activation was required for induction of both DEFB4 and cathelicidin, neutralization of IL-1beta prior to TLR-activation resulted in the loss of DEFB4 but not cathelicidin. Analysis of the cathelicidin and DEFB4 promoter regions revealed two NF-kappaB response elements present in the DEFB4 promoter region, and none in the cathelicidin promoter. In contrast, both genes contained vitamin D response elements, one in DEFB4 promoter and three in cathelicidin. These data suggested a potential mechanism by which IL-1beta could uniquely influence the TLR-induced expression of DEFB4 and not cathelicidin while both genes shared a requirement for vitamin D. Transfection of NF-kappaB p65, the predominant IL-1beta induced NF-kappaB subunit [15], [16], into monocytes resulted in a significant expression of DEFB4 only with VDR activation. In contrast, NF-kappaB p65 transfection decreased 1,25D3 induced cathelicidin, further highlighting the differential regulation of these two antimicrobial genes. However, the mechanism by which NF-kappaB p65 transfection inhibits cathelicidin is currently unclear and warrants further exploration. Taken together these data demonstrate a novel role for IL-1beta in the antimicrobial activity against intracellular pathogens, through the induction of DEFB4 in synergy with vitamin D. Furthermore, this suggests that there are two distinct vitamin D-dependent TLR-induced antimicrobial mechanisms, with DEFB4 expression also dependent on induction of IL-1beta.
###end p 62
###begin p 63
###xml 946 950 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Wilkinson1">[26]</xref>
###xml 1204 1208 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Adams1">[27]</xref>
###xml 1292 1307 1265 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1326 1330 1299 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Fremond1">[28]</xref>
###xml 1412 1416 1382 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Dinarello1">[29]</xref>
###xml 1482 1486 1449 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liao1">[30]</xref>
###xml 1616 1620 1580 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Dinarello1">[29]</xref>
###xml 1622 1626 1586 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Carl1">[31]</xref>
###xml 1627 1631 1591 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Orino1">[36]</xref>
###xml 1832 1836 1793 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Arend1">[37]</xref>
###xml 1292 1307 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1313 1319 <span type="species:ncbi:10090">murine</span>
In addition to induction of IL-1beta expression and VDR activation, triggering of TLR2/1 was found to modulate IL-1beta activity by increasing the cell's responsiveness to the secreted IL-1beta. The monocyte response to IL-1beta was upregulated by TLR2/1 activation through the simultaneous secretion of IL-1beta, upregulation of cell surface IL-1R1 and downregulation of baseline IL-1RA. Addition of IL-1beta to TLR2/1L stimulated monocytes resulted in synergistic upregulation of DEFB4, which reflects the increased IL-1beta responsiveness. On the other hand, IL-1beta plus 1,25D3 did not induce expression of DEFB4, presumably because the IL-1R1 was not upregulated and/or the IL-1RA was not downregulated. These findings provide a potential molecular mechanism for the previously known association of a high IL-1beta/low IL-1RA producing haplotype with pleural tuberculosis, a form of the disease that generally resolves without chemotherapy [26]. In addition, there is also an elevated level of 1,25D in the pleural effusion fluid compared to serum of the same individual, resulting in an optimal local microenvironment for the induction of antimicrobial responses, including cathelicidin and DEFB4 [27]. Furthermore, IL-1R1 has been demonstrated to be required for host defense against M. tuberculosis in a murine model [28]. Given that excessive activation of IL-1beta results in tissue injury and sepsis [29], IL-1beta activity is subject to negative feedback by the IL-1RA [30]. While both IL-1beta and IL-1RA are produced during inflammatory conditions, IL-1RA is also induced by anti-inflammatory signals [29], [31]-[36]. As such, the balance between IL-1beta and IL-1RA during an innate immune response plays a major role the pathogenesis of inflammatory diseases such as diabetes, arthritis, inflammatory bowel disease [37], and as presented here, TLR-mediated host defense mechanisms.
###end p 63
###begin p 64
###xml 77 80 77 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Liu2">[4]</xref>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Hertz1">[38]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Schauber1">[39]</xref>
###xml 228 232 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Shin1">[40]</xref>
###xml 233 237 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-TsutsumiIshii2">[42]</xref>
###xml 669 673 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Hertz1">[38]</xref>
###xml 675 679 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Nizet1">[43]</xref>
###xml 680 684 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Vora1">[45]</xref>
###xml 933 937 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Oppenheim1">[46]</xref>
Although TLR activation induces DEFB4 in both monocytes and epithelial cells [4], [38], [39], IL-1beta alone was not sufficient to induce expression of DEFB4 in monocytes, yet it is a potent inducer of DEFB4 in epithelial cells [40]-[42]. The differential regulation of antimicrobial peptide expression in monocytes vs. epithelial cells reflects the location of these cell types and the immunomodulatory properties of antimicrobial peptides. Epithelial cells form the barrier at which pathogens are initially encountered, and they efficiently utilize the antimicrobial peptide family of genes, for host defense at body surfaces interacting with the outside environment [38], [43]-[45]. However, in addition to their antimicrobial activity, beta-defensins and cathelicidin trigger inflammation, by their chemotactic activity for innate and adaptive immune cells such as monocytes, neutrophils, mast cells, dendritic cells and T cells [46]. At body surfaces the antimicrobial peptides are rapidly shed, such that this inflammatory activity is transient, but when released in tissues, the resulting inflammatory cell infiltrate contributes to immune-mediated injury, a complication of host defense in chronic infectious diseases including mycobacterial infections such as leprosy, tuberculosis and Buruli ulcer. Therefore, the more stringent regulation for monocytic expression of cathelicidin and DEFB4 could potentially represent a mechanism to prevent tissue injury in confined spaces.
###end p 64
###begin p 65
###xml 184 188 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Dinarello1">[29]</xref>
###xml 190 194 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Gamero1">[47]</xref>
###xml 298 320 295 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 322 343 319 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 349 368 346 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 368 372 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-Gamero1">[47]</xref>
###xml 373 377 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005810-ElOmar1">[51]</xref>
###xml 1031 1046 1022 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 199 205 <span type="species:ncbi:10090">murine</span>
###xml 298 320 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 322 343 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 349 368 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
###xml 843 848 <span type="species:ncbi:9606">human</span>
###xml 1031 1046 <span type="species:ncbi:1773">M. tuberculosis</span>
IL-1beta is clearly pivotal to host defense against microbial pathogens, required for cell recruitment and induction of inflammation, but also augmenting acquired lymphocyte responses [29], [47]. In murine models, a key role for IL-1 has been shown in immunity to a variety of pathogens, including Listeria monocytogenes, Staphylococcus aureus, and Helicobacter pylori[47]-[51]. Here, we have identified a novel mechanism by which IL-1beta contributes to human host defense, requiring convergence of the TLR-induced IL-1beta and VDR pathways, to trigger expression DEFB4. Furthermore, the data establish that the antimicrobial peptides, DEFB4 and cathelicidin, are required effector molecules in the TLR-induced antimicrobial response against intracellular mycobacteria in macrophages. Elucidation of the immune defense mechanisms utilized by human macrophages to combat pathogens provides possible targets for the development of new therapeutic strategies, potentially useful given the emergence of multidrug resistant strains of M. tuberculosis and other lethal microbes.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
(0.14 MB PDF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
(0.12 MB PDF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression.
###end article-title 72
###begin article-title 73
###xml 53 58 <span type="species:ncbi:9606">Human</span>
IFN-{gamma}- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37.
###end article-title 73
###begin article-title 74
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 70 96 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin.
###end article-title 74
###begin article-title 75
###xml 54 59 <span type="species:ncbi:9606">human</span>
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.
###end article-title 75
###begin article-title 76
IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway.
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 38 64 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Human macrophage host defense against Mycobacterium tuberculosis.
###end article-title 77
###begin article-title 78
###xml 9 10 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 62 88 62 88 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</underline>
###xml 62 88 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 92 97 <span type="species:ncbi:9606">human</span>
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes.
###end article-title 78
###begin article-title 79
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 98 103 <span type="species:ncbi:9606">human</span>
Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages.
###end article-title 79
###begin article-title 80
A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation.
###end article-title 80
###begin article-title 81
Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function.
###end article-title 81
###begin article-title 82
TGF-alpha regulates TLR expression and function on epidermal keratinocytes.
###end article-title 82
###begin article-title 83
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.
###end article-title 83
###begin article-title 84
###xml 34 39 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of the human prointerleukin 1 beta gene.
###end article-title 84
###begin article-title 85
Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses.
###end article-title 85
###begin article-title 86
###xml 89 94 <span type="species:ncbi:9606">human</span>
Requirements for two proximal NF-kappaB binding sites and IkappaB-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium.
###end article-title 86
###begin article-title 87
IL-1 beta and TNF-alpha regulation of the adenosine receptor (A2A) expression: differential requirement for NF-kappa B binding to the proximal promoter.
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 57 83 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 104 109 <span type="species:ncbi:9606">human</span>
Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells.
###end article-title 88
###begin article-title 89
Induction of direct antimicrobial activity through mammalian toll-like receptors.
###end article-title 89
###begin article-title 90
###xml 96 102 <span type="species:ncbi:10090">murine</span>
Killing of virulent M. tubeculosis by the reactive nitrogen intermediates produced by activated murine macrophages.
###end article-title 90
###begin article-title 91
###xml 47 53 <span type="species:ncbi:10090">murine</span>
###xml 69 95 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis.
###end article-title 91
###begin article-title 92
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.
###end article-title 92
###begin article-title 93
1-alpha,25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells.
###end article-title 93
###begin article-title 94
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
###end article-title 94
###begin article-title 95
Identification of nitric oxide synthase as a protective locus against tuberculosis.
###end article-title 95
###begin article-title 96
1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase.
###end article-title 96
###begin article-title 97
Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis.
###end article-title 97
###begin article-title 98
###xml 79 84 <span type="species:ncbi:9606">human</span>
Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid.
###end article-title 98
###begin article-title 99
###xml 94 120 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.
###end article-title 99
###begin article-title 100
The interleukin-1 family: 10 years of discovery.
###end article-title 100
###begin article-title 101
###xml 22 27 <span type="species:ncbi:9606">human</span>
Characterization of a human interleukin 1 inhibitor.
###end article-title 101
###begin article-title 102
Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages.
###end article-title 102
###begin article-title 103
###xml 27 32 <span type="species:ncbi:9606">human</span>
Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell.
###end article-title 103
###begin article-title 104
###xml 42 47 <span type="species:ncbi:9606">human</span>
Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor.
###end article-title 104
###begin article-title 105
###xml 97 102 <span type="species:ncbi:9606">human</span>
Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages.
###end article-title 105
###begin article-title 106
Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta.
###end article-title 106
###begin article-title 107
###xml 81 86 <span type="species:ncbi:9606">human</span>
IL-4 up-regulates IL-1 receptor antagonist gene expression and its production in human blood monocytes.
###end article-title 107
###begin article-title 108
The balance between IL-1 and IL-1Ra in disease.
###end article-title 108
###begin article-title 109
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 112 117 <span type="species:ncbi:9606">human</span>
Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2.
###end article-title 109
###begin article-title 110
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism.
###end article-title 110
###begin article-title 111
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin 2 is induced by interleukin-1beta in the corneal epithelial cells.
###end article-title 111
###begin article-title 112
###xml 14 19 <span type="species:ncbi:9606">human</span>
Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production.
###end article-title 112
###begin article-title 113
###xml 50 55 <span type="species:ncbi:9606">human</span>
NF-kappa B-mediated transcriptional regulation of human beta-defensin-2 gene following lipopolysaccharide stimulation.
###end article-title 113
###begin article-title 114
Innate antimicrobial peptide protects the skin from invasive bacterial infection.
###end article-title 114
###begin article-title 115
###xml 63 68 <span type="species:ncbi:9606">human</span>
Toll-like receptor 2-mediated expression of beta-defensin-2 in human corneal epithelial cells.
###end article-title 115
###begin article-title 116
Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells.
###end article-title 116
###begin article-title 117
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity.
###end article-title 117
###begin article-title 118
IL-1 can act as number one.
###end article-title 118
###begin article-title 119
###xml 101 122 <span type="species:ncbi:1280">Staphylococcus aureus</span>
MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus.
###end article-title 119
###begin article-title 120
###xml 88 94 <span type="species:ncbi:10090">murine</span>
Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis.
###end article-title 120
###begin article-title 121
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.
###end article-title 121
###begin article-title 122
Interleukin-1 polymorphisms associated with increased risk of gastric cancer.
###end article-title 122
###begin p 123
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 123
###begin p 124
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Grant support for this work: Robert L. Modlin (NIH RO1 AI047868), Valencia P. Walker (NIH K12 HD034610 and Robert Wood Johnson Foundation 053510)and Mirjam Schenk (Swiss National Foundation 117533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 124

